FDA slammed over Aduhelm OK as Biogen takes heat for $56k pr...

The FDA "has failed in its responsibility to protect patients and families from unproven treatments with known harms" in approving Biogen's Alzheimer's disease drug Aduhelm.

Study finds "alarming" hike in antidepressant costs during C...

Researchers in the UK have found that there was a four million rise in prescriptions for antidepressants in England during 2020, adding £139 million to NHS costs.

Divided Congress paves way for drug price reforms on Biden's...

Unless president Donald Trump is successful with legal challenges, Democratic rival Joe Biden looks to have won the White House in last week’s election but faces the challenges of a divided

Pharma may avoid worst-case drug pricing scenario as US elec...

Pharma may have avoided a worst case scenario amid the political upheavals in the US elections with the threat of tough drug price legislation lowered, with hawkish Democrats unlikely to wi

Gilead finally breaks its silence on remdesivir’s price

After weeks of speculation, Gilead Sciences has revealed its pricing plans for coronavirus drug remdesivir – and the rationale behind its decision.

‘Predatory’ drugmakers exploit FDA’s unapproved drug scheme;...